Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)
Status:
Active, not recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and the safety of paclitaxel
liposome and cisplatin compared with gemcitabine and cisplatin as first-line therapy in
advanced squamous non-small-cell lung cancer .